Bempedoic acid a good lipid-lowering alternative in select populations
18 Aug 2020
bởiJairia Dela Cruz
The first‐in‐class ATP–citrate lyase inhibitor bempedoic acid appears useful in the treatment of hypercholesterolaemia, yielding significant reductions in total cholesterol, low-density lipoprotein cholesterol, non–high-density lipoprotein cholesterol, apolipoprotein B, and high‐sensitivity C‐reactive protein, with an acceptable safety profile, according to the results of a meta-analysis.